Company / Gross Profit
MANGOCEUTICALS, INC. Gross Profit History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit
$250.4K
FY2025
5-year range
$4.8K / $431.5K
FY2023-FY2025
Trend
-42.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $4,850 to $250,386 over the past 2 years.
Based on SEC 10-K filings.
$250,386 in FY2025.
Improved from $4,850 to $250,386 over the past 2 years.
Gross Profit over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, gross profit decreased 42.0% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross ProfitValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $250.4K | -42.0% |
| FY2024 | $431.5K | +8796.9% |
| FY2023 | $4.8K | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026